- Home
- FHB vs SIGA Comparison
FHB vs SIGA Comparison
Compare FHB & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHB
- SIGA
- Stock Information
- Founded
- FHB 1858
- SIGA 1995
- Country
- FHB United States
- SIGA United States
- Employees
- FHB N/A
- SIGA N/A
- Industry
- FHB Major Banks
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- FHB Finance
- SIGA Health Care
- Exchange
- FHB Nasdaq
- SIGA Nasdaq
- Market Cap
- FHB 2.9B
- SIGA 422.9M
- IPO Year
- FHB 2016
- SIGA 1997
- Fundamental
- Price
- FHB $25.87
- SIGA $6.77
- Analyst Decision
- FHB Sell
- SIGA
- Analyst Count
- FHB 8
- SIGA 0
- Target Price
- FHB $26.81
- SIGA N/A
- AVG Volume (30 Days)
- FHB 1.1M
- SIGA 382.0K
- Earning Date
- FHB 07-25-2025
- SIGA 07-31-2025
- Dividend Yield
- FHB 4.02%
- SIGA 8.70%
- EPS Growth
- FHB 5.75
- SIGA N/A
- EPS
- FHB 1.84
- SIGA 0.67
- Revenue
- FHB $794,296,000.00
- SIGA $120,330,310.00
- Revenue This Year
- FHB $9.70
- SIGA N/A
- Revenue Next Year
- FHB $3.41
- SIGA $95.31
- P/E Ratio
- FHB $14.07
- SIGA $10.28
- Revenue Growth
- FHB N/A
- SIGA N/A
- 52 Week Low
- FHB $20.32
- SIGA $4.95
- 52 Week High
- FHB $28.80
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- FHB 62.49
- SIGA 61.28
- Support Level
- FHB $25.12
- SIGA $6.34
- Resistance Level
- FHB $26.72
- SIGA $7.07
- Average True Range (ATR)
- FHB 0.61
- SIGA 0.22
- MACD
- FHB 0.12
- SIGA 0.02
- Stochastic Oscillator
- FHB 75.78
- SIGA 71.70
About FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.